In March, we will finally be back on site at FOKO 2022. The training congress of the BFV (Berufsverband der Frauenärzte e.V.) will take place in the CCD. Stadthalle Düsseldorf. We are looking forward to talking to numerous gynaecologists and presenting our GynTect® screening test as well as our current state of research to them.
This year, the EUROGIN - International multidisciplinary HPV Congress 2022 will take place in Düsseldorf. We will participate in the professional discourse with own contributions
The Investor Days Thüringen will take place again on 14 and 15 June. The event bring the start-up community together with investors. Of course, we will be there again. We are looking forward to see you.
Oncgnostics will be attending the Vulvovaginal Disease Update in Dublin from 15-16 July. This course is in preparation for the subsequent XXVI World Congress of The international Society for the Study of Vulvovaginal Disease (ISSVD). The course will be led by international experts in the field.
The XXVI World Congress of the international Society for the Study of Vulvovaginal Disease (ISSVD) will take place from 18-20 July in Dublin. oncgnostics GmbH will be there with its own booth. We will inform ourselves about the latest trends in the field of vulvovaginal diseases and present our research results.
From November 14-17, 2022, MEDICA, the world's leading medical trade fair, will again take place as a presence event! We will be present on site and look forward to welcoming you in hall 15, booth K10!
At EUROGIN 2023 (International Multidisciplinary HPV Congress) in Bilbao we will present ourselves with our own booth. In addition, we will participate in the scientific discourse with our own presentations.
"MEDICA 2023 - the whole world of medicine meets here", is a self-description of the trade fair, which will take place in Düsseldorf from 13 to 16 November. With over 4,500 exhibitors from more than 66 countries and 81,000 visitors, it is one of the largest trade fairs of its kind in the world. We […]
At the 36th German Cancer Congress in Berlin, we will be presenting the current status of the OncSaliva study in a poster exhibition. The study aims to develop epigenetic tumor markers for the detection of head and neck tumors in saliva samples for use as in-vitro diagnostics.
EUROGIN is the world’s leading international congress on HPV infection and associated cancers. We will present ourselves at our booth.